Track the 에스엘에스바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 에스엘에스바이오 has logged 22 insider filings. Market capitalisation: €29.6bn. The latest transaction was disclosed on 10 March 2026 (Other). Among the most active insiders: 문해란. Every trade is openly available.
22
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,445 of 28,796 companies
8.0
score / 100
Value
13
Quality
3
FCF yld-13%
Earn yld-17%
EV/EBITDA·
ROE-59%
Gross mgn-49%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.